良性和恶性瘤的不同进化动态
George Butler1,2, Joanna Baker3,4, Sarah R Amend2
1University College London Cancer Institute, University College London, London WC1E 6DD, United Kingdom.
概括
良性和恶性瘤对健康有不同的影响. 恶性瘤的患病率与体型进化速度较慢有关,这表明快速进化的物种具有癌症防御能力.
科学领域:
- 比较性瘤学研究
- 进化生物学是进化的生物学.
- 癌症研究 癌症研究
背景情况:
- 良性和恶性瘤对生物体的健康有不同的影响.
- 相对瘤学研究往往不区分瘤类型.
- 了解瘤宏观进化驱动因素至关重要.
研究的目的:
- 为了调查良性与恶性瘤患病率的明显的宏观进化驱动因素.
- 确定瘤类型,体质,体型演变和血统多样化率之间的关系.
- 评估鸟类和哺乳动物之间的这些关系的差异.
主要方法:
- 利用贝叶斯的遗传学框架. 贝叶斯的遗传学框架.
- 分析了鸟类和哺乳动物物种中的瘤流行率.
- 检查了与人体质量,体型进化的速度和血统多样化的关联.
主要成果:
- 良性和恶性瘤的患病率随着人体质量增加而增加.
- 恶性瘤的患病率与身体大小演变的速度有关.
- 血统多样化率与鸟类的两种瘤类型都有正相关,但哺乳动物没有.
结论:
- 显著的宏观进化因素影响良性和恶性瘤的流行.
- 适应性癌症防御机制可能与快速发展的血统有关.
- 基因组架构和物种化动态的差异可以解释鸟类和哺乳动物之间的差异.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K


